Cancer and cardiovascular diseases are the leading causes of death in high-income countries. Cardiovascular complications can be found in cancer patients, being the result of so-called ‘cardio-toxicity’. Therefore, it becomes essential to thoroughly investigate the origin of cardiac damage and the strategy to prevent it or to reverse the negative remodelling associated with cardiotoxicity. In this review the beneficial effects of physical exercise in cancer patients were analysed, particularly to prevent cardio-toxicity before its clinical manifestation. According to the relevance of exercise, we suggest strategies for exercise prescription with a tailored approach in these patients. In conclusion, physical exercise seems to be a promising and effective treatment for cancer patients during and after therapy and seems to counteract the negative effects induced by drugs on the cardiovascular system. Exercise prescription should be tailored according to patient’s individual characteristics, to the drugs administered, to the personal history, and to his/her response to exercise, taking into account that different types of training can be prescribed according also to the patient’s choice. A cardiological evaluation including exercise testing is essential for an appropriate prescription of exercise in these patients.
BrayFFerlayJSoerjomataramI, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin2018; 68: 394–424.
2.
TuHWenCPTsaiSP, et al.Cancer risk associated with chronic diseases and disease markers: Prospective cohort study. BMJ2018; 360: k134–k134.
3.
SchmielauJRickOReuss-BorstM, et al.Rehabilitation of cancer survivors with long-term toxicities. Oncol Res Treat2017; 40: 764–771.
4.
KunisadaKNegoroSToneE, et al.Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci U S A2000; 97: 315–319.
5.
KirkhamAAShaveREBlandKA, et al.Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: A proof-of-concept RCT. Int J Cardiol2017; 245: 263–270.
6.
KirkhamAAEvesNDShaveRE, et al.The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: A RCT. Breast Cancer Res Treat2018; 167: 719–729.
7.
BlanchardCMCourneyaKSSteinK. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: Results from the American Cancer Society's SCS-II. J Clin Oncol2008; 26: 2198–2204.
8.
SchmidDLeitzmannMF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: A systematic review and meta-analysis. Ann Oncol2014; 25: 1293–1311.
9.
WestMAAsherRBrowningM, et al.Validation of preoperative cardiopulmonary exercise testing-derived variables to predict in-hospital morbidity after major colorectal surgery. Br J Surg2016; 103: 744–752.
10.
VincentFLaboureyJLLeobonS, et al.Effects of a home-based walking training program on cardiorespiratory fitness in breast cancer patients receiving adjuvant chemotherapy: A pilot study. Eur J Phys Rehabil Med2013; 49: 319–329.
11.
StefaniLKlikaRMascheriniG, et al.Effects of a home-based exercise rehabilitation program for cancer survivors. J Sports Med Phys Fitness2019; 59: 846–852.
12.
WenzelJAGriffithKAShangJ, et al.Impact of a home-based walking intervention on outcomes of sleep quality, emotional distress, and fatigue in patients undergoing treatment for solid tumors. Oncologist2013; 18: w476–w484.
13.
GriffithKWenzelJShangJ, et al.Impact of a walking intervention on cardiorespiratory fitness, self-reported physical function, and pain in patients undergoing treatment for solid tumors. Cancer2009; 115: 4874–4884.
14.
van WaartHStuiverMMvan HartenWH, et al.Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: Results of the PACES Randomized Clinical Trial. J Clin Oncol2015; 33: 1918–1927.
15.
LipsettABarrettSHarunaF, et al.The impact of exercise during adjuvant radiotherapy for breast cancer on fatigue and quality of life: A systematic review and meta-analysis. Breast2017; 32: 144–155.
16.
IrwinMLCartmelBGrossCP, et al.Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol2015; 33: 1104–1111.
17.
CormiePGalvaoDASpryN, et al.Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: A randomised controlled trial. BJU Int2015; 115: 256–266.
18.
AgostiniDNatalucciVBaldelliG, et al.New insights into the role of exercise in inhibiting mTOR signaling in triple-negative breast cancer. Oxid Med Cell Longev2018; 2018: 1–19.
19.
JonesLWFelsDRWestM, et al.Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila)2013; 6: 925–937.
20.
PanHGrayRBraybrookeJ, et al.20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med2017; 377: 1836–1846.
21.
GanzPAHahnEE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol2008; 26: 759–767.
22.
HayesSCSteeleMSpenceR, et al.Can exercise influence survival following breast cancer: Results from a randomised, controlled trial. J Clin Oncol2017; 35: S10067–S10067.
23.
LahartIMMetsiosGSNevillAM, et al.Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies. Acta Oncol2015; 54: 635–654.
24.
BrownJCTroxelABKyB, et al.Dose-response effects of aerobic exercise among colon cancer survivors: A randomized phase II trial. Clin Colorectal Cancer2018; 17: 32–40.
25.
PaschosKACanovasDBirdNC. The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell Signal2009; 21: 665–674.
26.
MeyerhardtJAHeseltineDNiedzwieckiD, et al.Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: Findings from CALGB 89803. J Clin Oncol2006; 24: 3535–3541.
27.
RichmanELKenfieldSAStampferMJ, et al.Physical activity after diagnosis and risk of prostate cancer progression: Data from the cancer of the prostate strategic urologic research endeavor. Cancer Res2011; 71: 3889–3895.
28.
HudsonMMNessKKGurneyJG, et al.Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA2013; 309: 2371–2381.
29.
KrischerJPEpsteinSCuthbertsonDD, et al.Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience. J Clin Oncol1997; 15: 1544–1552.
30.
BardiaAArieasETZhangZ, et al.Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer. Breast Cancer Res Treat2012; 131: 907–914.
31.
SinglaAKumarGBardiaA. Personalizing cardiovascular disease prevention among breast cancer survivors. Curr Opin Cardiol2012; 27: 515–524.
32.
GohLGWelbornTADhaliwalSS. Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: A mortality follow-up study. BMC Womens Health2014; 14: 118–118.
33.
BarrosoLCMuroECHerreraND, et al.Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: A validation study. Scand J Prim Health Care2010; 28: 242–248.
34.
Lee K, Tripathy D, Demark-Wahnefried W, et al. Effect of aerobic and resistance exercise intervention on cardiovascular disease risk in women with early-stage breast cancer: A randomized clinical trial. JAMA Oncol 2019; 5: 710–714.
35.
JonesLWHabelLAWeltzienE, et al.Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer. J Clin Oncol2016; 34: 2743–2749.
36.
PalomoARayRMJohnsonL, et al.Associations between exercise prior to and around the time of cancer diagnosis and subsequent cardiovascular events in women with breast cancer: A Women's Health Initiative (WHI) analysis. J Am Coll Cardiol2017; 69: S1774–S1774.
37.
AdamsSCDeLoreyDSDavenportMH, et al.Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial. Cancer2017; 123: 4057–4065.
38.
WestonKSWisloffUCoombesJS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: A systematic review and meta-analysis. Br J Sports Med2014; 48: 1227–1234.
39.
ThompsonPDBuchnerDPinaIL, et al.Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation2003; 107: 3109–3116.
40.
MyersJPrakashMFroelicherV, et al.Exercise capacity and mortality among men referred for exercise testing. N Engl J Med2002; 346: 793–801.
41.
FungCSessoHDWilliamsAM, et al.Multi-institutional assessment of adverse health outcomes among north american testicular cancer survivors after modern cisplatin-based chemotherapy. J Clin Oncol2017; 35: 1211–1222.
42.
KaminskyLAArenaRBeckieTM, et al.The importance of cardiorespiratory fitness in the United States: The need for a national registry: A policy statement from the American Heart Association. Circulation2013; 127: 652–662.
43.
CourneyaKSMcKenzieDCMackeyJR, et al.Effects of exercise dose and type during breast cancer chemotherapy: Multicenter randomized trial. J Natl Cancer Inst2013; 105: 1821–1832.
de PalevilleDTToppRVSwankAM. Effects of aerobic training prior to and during chemotherapy in a breast cancer patient: A case study. J Strength Cond Res2007; 21: 635–637.
46.
KirkhamAAPatersonDIPradoCM, et al.Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: A 3-arm parallel group phase II randomized controlled trial in early breast cancer. BMC Cancer2018; 18: 864–864.
47.
KirkhamAABonsignoreABlandKA, et al.Exercise prescription and adherence for breast cancer: One size does not FITT all. Med Sci Sports Exerc2018; 50: 177–186.
48.
BovelliDPlataniotisGRoilaF. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO clinical practice guidelines. Ann Oncol2010; 21: v277–v282.
49.
KhanHKunutsorSRauramaaR, et al.Cardiorespiratory fitness and risk of heart failure: A population-based follow-up study. Eur J Heart Fail2014; 16: 180–188.
50.
KodamaSSaitoKTanakaS, et al.Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: A meta-analysis. JAMA2009; 301: 2024–2035.
51.
HowdenEJBigaranABeaudryR, et al.Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. Eur J Prev Cardiol2019; 26: 305–315.
52.
JonesLWCourneyaKSMackeyJR, et al.Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol2012; 30: 2530–2537.
53.
HughesDCLenihanDJHarrisonCA, et al.Exercise intervention for cancer survivors with heart failure: Two case reports. J Exerc Sci Fit2011; 9: 65–73.
54.
NagyACGulAcsiBPCserEpZ, et al.Late cardiac effect of anthracycline therapy in physically active breast cancer survivors – a prospective study. Neoplasma2017; 64: 92–100.
55.
JärvelLSSarasteMNiinikoskiH, et al.Home-based exercise training improves left ventricle diastolic function in survivors of childhood ALL: A tissue doppler and velocity vector imaging study. Pediatr Blood Cancer2016; 63: 1629–1635.
56.
HaykowskyMJMackeyJRThompsonRB, et al.Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training. Clin Cancer Res2009; 15: 4963–4967.
57.
Gilchrist SC, Barac A, Ades PA, et al. Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: A scientific statement from the American Heart Association. Circulation 2019: 139: e997–e1012.
58.
ScottJMNilsenTSGuptaD, et al.Exercise therapy and cardiovascular toxicity in cancer. Circulation2018; 137: 1176–1191.
59.
LohKPLinPJUthJ, et al.Exercise for managing cancer- and treatment-related side effects in older adults. J Geriatr Oncol2018; 9: 405–410.
60.
JonesLWEvesNDScottJM. Bench-to-bedside approaches for personalized exercise therapy in cancer. Am Soc Clin Oncol Educ Book2017; 37: 684–694.
61.
ArgilesJMBusquetsSLopez-SorianoFJ, et al.Are there any benefits of exercise training in cancer cachexia?J Cachexia Sarcopenia Muscle2012; 3: 73–76.
62.
AntunesJMMFerreiraRMPMoreira-GoncalvesD. Exercise training as therapy for cancer-induced cardiac cachexia. Trends Mol Med2018; 24: 709–727.
63.
Swedish National Institute of Public Health. Physical activity in the prevention and treatment of disease. 2010.
MinaDSLangelierDAdamsSC, et al.Exercise as part of routine cancer care. Lancet Oncol2018; 19: e433–e436.
66.
JeffordMRowlandJGrunfeldE, et al.Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA. Br J Cancer2013; 108: 14–20.
67.
SchmitzKHCourneyaKSMatthewsC, et al.American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc2010; 42: 1409–1426.
68.
CorreaCRLittHIHwangWT, et al.Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol2007; 25: 3031–3037.
69.
Powell KE, King AC, Buchner DM, et al. The scientific foundation for the physical activity guidelines for Americans, 2nd edition. J Phys Act Health 2018: 17; 1–11.
70.
StrasserBSteindorfKWiskemannJ, et al.Impact of resistance training in cancer survivors: A meta-analysis. Med Sci Sports Exerc2013; 45: 2080–2090.
71.
World Health Organization. WHO guidelines approved by the Guidelines Review Committee. Global recommendations on physical activity for health, Geneva: World Health Organization, 2010.
72.
KraemerWJRatamessNA. Fundamentals of resistance training: Progression and exercise prescription. Med Sci Sports Exerc2004; 36: 674–688.
73.
PersingerRFosterCGibsonM, et al.Consistency of the talk test for exercise prescription. Med Sci Sports Exerc2004; 36: 1632–1636.
74.
BorgGA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc1982; 14: 377–381.
75.
BonifaziMSumanALCambiaggiC, et al.Changes in salivary cortisol and corticosteroid receptor-alpha mRNA expression following a 3-week multidisciplinary treatment program in patients with fibromyalgia. Psychoneuroendocrinology2006; 31: 1076–1086.
76.
BinderRKWonischMCorraU, et al.Methodological approach to the first and second lactate threshold in incremental cardiopulmonary exercise testing. Eur J Cardiovasc Prev Rehabil2008; 15: 726–734.
77.
MoraSCookNBuringJE, et al.Physical activity and reduced risk of cardiovascular events: Potential mediating mechanisms. Circulation2007; 116: 2110–2118.
78.
MargariaRCerretelliPAghemoP, et al.Energy cost of running. J Appl Physiol1963; 18: 367–370.
79.
DolanLBCampbellKGelmonK, et al.Interval versus continuous aerobic exercise training in breast cancer survivors–a pilot RCT. Support Care Cancer2016; 24: 119–127.
80.
TooheyKPumpaKLArnoldaL, et al.A pilot study examining the effects of low-volume high-intensity interval training and continuous low to moderate intensity training on quality of life, functional capacity and cardiovascular risk factors in cancer survivors. Peer J2016; 4: e2613–e2613.
81.
MolassiotisACharalambousATaylorP, et al.The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: A feasibility randomised trial. Support Care Cancer2015; 23: 1637–1645.
82.
Rosero ID, Ramirez-Velez R, Lucia A, et al. Systematic review and meta-analysis of randomized, controlled trials on preoperative physical exercise interventions in patients with non-small-cell lung cancer. Cancers (Basel) 2019; 11: 944.
